Patent Yard Sign in
Expired Canadian patentCanada

Derivatives and precursors of captopril and its analogues and methods for preparing captopril and its analogues therefrom

CA 1338867 C · Owner: Sepracor, Inc. · Inventors: Zepp, Charles M.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

This invention relates to novel methods for converting a diastereomeric mixture of S-protected derivatives of an orally active inhibitor of an angiotensin-converting enzyme (ACE) and its analogues into its separate optically resolved diastereomeric components. Specifically the invention relates to methods for the preparation of optically purified captopril for the preparation of optically purified captopril and its analogs from racemic precursors. This resolution process is achieved through the fractional crystallization of Sprotected derivatives of captopril and its precursors which derivatives are useful for the reason that they are (1) easily prepared from novel precursors (2) …

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Granted January 21, 1997. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended January 21, 2014.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledAugust 24, 1989
GrantedJanuary 21, 1997
Term endedJanuary 21, 2014
Patent numberCA 1338867 C
Classification (IPC)C07D207/16 +2 more

Timeline

Timeline From CIPO dates

199019931996199920022005200820112014Application filedAug 24, 1989Patent grantedJan 21, 1997Term endedJan 21, 2014

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.